The negativity around sales is unexpected. If their yearly...

The negativity around sales is unexpected. If their yearly income ends up above 60m and last year was 42 m what is the problem. That is near 50% growth. What do people want or demand. 100%. This is a medical product and change occurs slowly but it is occurring. We allow a few posters one who invests in a company that has raised over 1B dollars with minimal income to cloud our judgement. The issue with PNV is the previous price of 4 dollars was never justified. We all agree with this and the company has been measured on this metric since. The sales never justified this price and the market adjusted accordingly. I know their expenses have increased but this is a growth company. What will sales be like when we have Ulcer and burn indications approved. This is a 1-3 year story. The current price decrease reflects a very uncertain market, nothing else. The world is a unsettled place at the moment. This company is not for every investor. Yes there is a PNV cheer squad but so what. Has that at times clouded our judgment. Probably yes but that is investing. The experts rarely get it right 100% of the time so please there are no prophets here. But this group believes in the product and people running the company and growth prospects. Yes I am disappointed with the price drop but unless you are selling in the medium term this should not matter. We can discuss this until we grow old. Pointless. Let time dictate who is right. If in 1-2-3 years we are still arguing about sales of 60-90m and price of 1.50 I would be shocked and proven wrong. But that is life.
To the believers, hold the line.
Bill